We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.74B
1-Year Est. Return 34.09%
This Fund
S&P 500
This Quarter Est. Return
+6.13%
1 Year Est. Return
+34.09%
3 Year Est. Return
+68.11%
5 Year Est. Return
+74.85%
10 Year Est. Return
+251.8%
AUM
$995M
AUM Growth
+$58.3M
Cap. Flow
+$1.53M
Cap. Flow %
0.15%
Top 10 Hldgs %
31.03%
Holding
293
New
25
Increased
75
Reduced
95
Closed
36

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$11.7M
2
Y
Alleghany Corp
Y
+$6.27M
3
AON icon
Aon
AON
+$4.05M
4
MTRX icon
Matrix Service
MTRX
+$3.45M
5
SON icon
Sonoco
SON
+$2.78M

Top Sells

Rank Stock Value
1
DD
Du Pont De Nemours E I
DD
+$11.3M
2
AGN
Allergan plc
AGN
+$5.47M
3
COHR icon
Coherent
COHR
+$2.22M
4
MET icon
MetLife
MET
+$2.02M
5
MOS icon
The Mosaic Company
MOS
+$1.83M

Sector Composition

Rank Sector Weight
1 Technology 21.63%
2 Industrials 17.11%
3 Healthcare 14.09%
4 Financials 13.29%
5 Consumer Discretionary 12.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABB
126
DELISTED
ABB Ltd
ABB
$953K 0.1%
38,490
+1,350
+4% +$32.3K
PEG icon
127
Public Service Enterprise Group
PEG
$35.3B
$920K 0.09%
19,892
+2,726
+16% +$123K
RDS.A
128
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$874K 0.09%
14,419
DGX icon
129
Quest Diagnostics
DGX
$27.4B
$854K 0.09%
9,115
-400
-4% -$42.5K
PPT
130
Franklin Premier Income Trust
PPT
$317M
-149,800
Closed -$807K
ANDV
131
DELISTED
Andeavor
ANDV
$846K 0.09%
8,200
ILF icon
132
iShares Latin America 40 ETF
ILF
$3.92B
$841K 0.08%
23,975
+290
+1% +$9.79K
XBI icon
133
State Street SPDR S&P Biotech ETF
XBI
$10.6B
$840K 0.08%
9,700
LIT icon
134
Global X Lithium & Battery Tech ETF
LIT
$1.49B
$830K 0.08%
+22,195
New +$733K
MDT icon
135
Medtronic
MDT
$119B
$803K 0.08%
10,331
SSD icon
136
Simpson Manufacturing
SSD
$7.06B
$801K 0.08%
16,330
-50
-0.3% -$2.23K
VZ icon
137
Verizon
VZ
$202B
$793K 0.08%
16,020
+1,461
+10% +$68.7K
OME
138
DELISTED
Omega Protein
OME
$783K 0.08%
47,000
+500
+1% +$8.13K
BWA icon
139
BorgWarner
BWA
$13.1B
$773K 0.08%
17,137
WPG
140
DELISTED
Washington Prime Group Inc.
WPG
$759K 0.08%
10,126
-93
-0.9% -$7.21K
ALK icon
141
Alaska Air
ALK
$4.49B
$755K 0.08%
+9,900
New +$809K
AVX
142
DELISTED
AVX Corporation
AVX
$717K 0.07%
39,325
-2,600
-6% -$45.1K
BHB icon
143
Bar Harbor Bankshares
BHB
$681M
$708K 0.07%
22,585
-175
-0.8% -$4.9K
TRN icon
144
Trinity Industries
TRN
$2.27B
$702K 0.07%
30,558
-278
-0.9% -$5.74K
LAND
145
Gladstone Land Corp
LAND
$413M
$674K 0.07%
49,500
+1,500
+3% +$19.1K
HDNG
146
DELISTED
Hardinge Inc
HDNG
$667K 0.07%
43,700
-11,500
-21% -$155K
FWONA icon
147
Liberty Media Series A
FWONA
$21.6B
$646K 0.07%
18,503
-118
-0.6% -$3.96K
JEF icon
148
Jefferies Financial Group
JEF
$11.1B
$640K 0.06%
28,297
WDC icon
149
Western Digital
WDC
$153B
$633K 0.06%
9,694
-62
-0.6% -$4.11K
T icon
150
AT&T
T
$174B
$615K 0.06%
20,772
+1,227
+6% +$34.8K

Similar funds

Shufro Rose & Co's Q3 2017 Portfolio in Review

As of Q3 2017, Shufro Rose & Co held 293 positions worth $995M, up 6.2% from $936M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Shufro Rose & Co's Q3 2017 filing shows 25 new, 75 increased, 95 reduced and 36 closed positions. Its largest new stake was Alleghany Corp: 10,755 shares worth $5.96M. The largest sale was Du Pont De Nemours E I, an estimated $11.3M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Industrials and Healthcare.

  • Shufro Rose & Co's largest Q3 2017 buy was Alleghany Corp: 10,755 shares worth $5.96M.
  • Shufro Rose & Co added most to DuPont de Nemours in Q3 2017, an estimated $11.7M increase.
  • Shufro Rose & Co's biggest Q3 2017 reduction was Allergan plc, cutting an estimated $5.47M.
  • Shufro Rose & Co fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $11.3M.
  • Shufro Rose & Co's ten largest holdings make up 31% of its $995M portfolio in Q3 2017.
  • Shufro Rose & Co opened 25 new positions and closed 36 in Q3 2017.
  • Shufro Rose & Co's portfolio value rose 6.2% quarter-over-quarter to $995M.

Based on Shufro Rose & Co's 13F filing for Q3 2017, filed 13 Nov 2017.